argenx Presents New VYVGART Data and argenx stock Trades EUR 816.40
Published on 10/04/2026 at 18:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 29, 2026, argenx announced new VYVGART data for the AANEM Annual Meeting and MGFA Scientific Session, while argenx stock stood at EUR 816.40 in weekend trading on October 4, 2026. The company announcement was published by GlobeNewswire.
Weekend trading at Lang & Schwarz
Lang & Schwarz quoted argenx at EUR 816.40 at 6:46 p.m. CEST on October 4, 2026, unchanged at 0.00 percent versus the close of EUR 816.40 at Lang & Schwarz on October 2, 2026. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of argenx stock.
The last Xetra trading day
The reference close was EUR 816.40 at Lang & Schwarz on October 2, 2026. The quote was unchanged against that close in weekend trading on October 4, 2026.
New VYVGART data
The September 29 announcement said argenx would present clinical, long-term and real-world data for VYVGART in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. It also covered empasiprubart and adimanebart, reflecting progress across the company's neuromuscular pipeline, according to GlobeNewswire.
The next Xetra session
The next Xetra session is scheduled for October 5, 2026.
